Literature DB >> 8547519

Infections associated with Bartonella species in persons infected with human immunodeficiency virus.

R L Regnery1, J E Childs, J E Koehler.   

Abstract

Two members of the genus Bartonella, Bartonella quintana (formerly Rochalimaea quintana) and Bartonella henselae (formerly Rochalimaea henselae), have recently been recognized as agents of severe or fatal disease in patients infected with human immunodeficiency virus (HIV). The development of infection with B. henselae in HIV-infected individuals has been associated with traumatic contact with cats (scratches or bites), and domestic cats have been identified as a major reservoir for this organism. Specific information regarding the transmission of B. henselae to humans is not yet available, but common-sense precautions that minimize exposure to cat-associated organisms are appropriate. Preliminary accounts suggest that B. quintana infections are more common than B. henselae infections among HIV-infected individuals in San Francisco. The source of infection with B. quintana and the mechanism of its transmission remain unknown.

Entities:  

Mesh:

Year:  1995        PMID: 8547519     DOI: 10.1093/clinids/21.supplement_1.s94

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Fever, weight loss, and night sweats: infection or malignancy?

Authors:  A J Winter; M J Wiselka; J T Wilde; K W Radcliffe
Journal:  Sex Transm Infect       Date:  1998-12       Impact factor: 3.519

Review 2.  Current knowledge of Bartonella species.

Authors:  M Maurin; R Birtles; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

3.  Dynamics of Co-Infection with Bartonella henselae Genotypes I and II in Naturally Infected Cats: Implications for Feline Vaccine Development.

Authors:  Camille Huwyler; Nadja Heiniger; Bruno B Chomel; Minsoo Kim; Rickie W Kasten; Jane E Koehler
Journal:  Microb Ecol       Date:  2017-02-02       Impact factor: 4.552

Review 4.  Bartonella infection in animals: carriership, reservoir potential, pathogenicity, and zoonotic potential for human infection.

Authors:  E B Breitschwerdt; D L Kordick
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

5.  Serodiagnosis of Bartonella bacilliformis infection by indirect fluorescence antibody assay: test development and application to a population in an area of bartonellosis endemicity.

Authors:  J Chamberlin; L Laughlin; S Gordon; S Romero; N Solórzano; R L Regnery
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

6.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

Review 7.  Emerging zoonoses and vector-borne infections affecting humans in Europe.

Authors:  R M Vorou; V G Papavassiliou; S Tsiodras
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

8.  Cat-Scratch Disease in the United States, 2005-2013.

Authors:  Christina A Nelson; Shubhayu Saha; Paul S Mead
Journal:  Emerg Infect Dis       Date:  2016-10       Impact factor: 6.883

9.  Bartonella quintana in body lice and head lice from homeless persons, San Francisco, California, USA.

Authors:  Denise L Bonilla; Hidenori Kabeya; Jennifer Henn; Vicki L Kramer; Michael Y Kosoy
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

10.  Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain.

Authors:  Immaculada Pons; Isabel Sanfeliu; María Mercedes Nogueras; Montserrat Sala; Manuel Cervantes; M José Amengual; Ferran Segura
Journal:  BMC Infect Dis       Date:  2008-05-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.